Chronic Constipation Clinical Trial
Official title:
Kiwifruit, Prunes, & Fiber for Abdominal and Bowel Symptoms in US Patients With Chronic Constipation
Verified date | October 2019 |
Source | University of Michigan |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This is a parallel group pilot study comparing the efficacy green kiwifruit, prunes or psyllium on abdominal and bowel related symptoms in US patients with chronic constipation patients.
Status | Completed |
Enrollment | 78 |
Est. completion date | October 10, 2019 |
Est. primary completion date | October 10, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: 1. Presence of functional constipation according to modified ROME IV diagnostic criteria*5b i. Must include two or more of the following: 1. Straining more than 25% of defecations 2. Lumpy or hard stools more than 25% of defecations 3. Sensation of incomplete evacuation more than 25% of defecations 4. Sensation of anorectal obstruction/blockage more than 25% of defecations 5. Manual manoeuvres to facilitate more than 25% of defecations (e.g. digital evacuation, support of pelvic floor) 6. Fewer than three defecations per week ii. Loose stools are rarely present without the use of laxatives * Criteria fulfilled for the last 3 months with symptom onset at least 6 months prior to diagnosis For the purposes of this study, patients with abdominal pain will be included, but patients with severe pain (defined as average daily abdominal pain score of 7 or higher during the screening period) will be excluded. Patients with an appropriate level of GI symptoms despite taking stable doses (>3 months) of SSRI's, tricyclics or SNRIs will be allowed to enroll. Exclusion Criteria: Potential participants will be excluded if they have alarm features (GI bleeding, weight loss, unexplained iron deficiency anaemia, significant family history of colorectal cancer or IBD), anal fissures, significant chronic diseases (cardiovascular, cancer, renal failure, inflammatory bowel disease), previous gastrointestinal surgery (except appendectomy or cholecystectomy), neurological diseases (e.g. multiple sclerosis, spinal cord injury, CVA). Patients taking opiates will not be eligible to participate. Women who are pregnant, breastfeeding or planning a pregnancy in the 2 months post selection (trial period) will be excluded. As above, patients with severe IBS symptoms will be excluded (defined as average daily abdominal pain score of 7 or higher during the screening period). |
Country | Name | City | State |
---|---|---|---|
United States | University of Michigan | Ann Arbor | Michigan |
Lead Sponsor | Collaborator |
---|---|
University of Michigan |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | : Change in complete spontaneous bowel movement (CSBM) | Complete spontaneous bowel movement will be recorded. This will be compared to the baseline, run-in periods, and follow-up period. | 8 weeks | |
Secondary | Change in SBM (spontaneous bowel movements) | Spontaneous bowel movements will be recorded. This will be compared to the baseline, run-in periods, and follow-up period. | 8 weeks | |
Secondary | stool consistency | Bristol stool form scale (1-7, lower scores are consistent with constipation; higher scores are consistent with diarrhea) will be recorded. This will be averaged and compared to the baseline, run-in period, and follow-up period. | 8 weeks | |
Secondary | straining | 5 point Likert scale for straining will be recorded (1-5, lower scores= less straining, higher scores = more straining). This will be averaged and compared to the baseline, run-in periods, and follow-up period. | 8 weeks | |
Secondary | abdominal pain | Daily score (0-10) for abdominal pain will be recorded (0=no pain, 10= severe pain). This will be averaged and compared to the baseline, run-in periods, and follow-up period. | 8 weeks | |
Secondary | abdominal discomfort | Daily score (0-10) for abdominal discomfort will be recorded (0=no pain, 10= severe pain). This will be averaged and compared to the baseline, run-in periods, and follow-up period. | 8 weeks | |
Secondary | bloating | Daily score (0-10) for abdominal bloating will be recorded (0=no pain, 10= severe pain). This will be averaged and compared to the baseline, run-in periods, and follow-up period. | 8 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05980988 -
Effectiveness and Safety of Probiotic in Regulating Chronic Constipation
|
N/A | |
Recruiting |
NCT03819062 -
Sacral Neuromodulation as Treatment for Chronic Constipation
|
N/A | |
Completed |
NCT00765882 -
Phase III, Randomized, Double-Blind, Placebo-Controlled, Trial of Linaclotide Administered to Patients With Chronic Constipation
|
Phase 3 | |
Completed |
NCT00730171 -
An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation
|
Phase 3 | |
Completed |
NCT00354575 -
Effect of Chinese Herb on Chronic Constipation for Residents in Long-Term Care Units
|
Phase 2 | |
Active, not recruiting |
NCT03119584 -
Efficacy of Linaclotide in Type II Diabetics With Chronic Constipation
|
Phase 4 | |
Completed |
NCT00765999 -
An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation
|
Phase 3 | |
Completed |
NCT01793753 -
Effect of Propofol on Internal Anal Sphincter Pressure During ARM
|
N/A | |
Completed |
NCT00746200 -
Acupuncture for Chronic Constipation
|
Phase 3 | |
Enrolling by invitation |
NCT00671684 -
Endoscopic Mucosal Resection (EMR) for Diagnosis of Hirschsprung's Disease
|
Phase 1/Phase 2 | |
Completed |
NCT00391820 -
Evaluate the Safety and Efficacy of a 5-HT4 Agonist in Chronic Constipation (ACCORD Trial)
|
Phase 2 | |
Completed |
NCT00404040 -
Movicol in Childhood Constipation (ProMotion Study)
|
Phase 2 | |
Completed |
NCT02281630 -
Phase II Dose-Finding Study of KWA-0711 in Patients With Chronic Constipation (CC)
|
Phase 2 | |
Completed |
NCT00256984 -
Study of Stapled Transanal Rectal Resection (STARR) Surgery in Refractory Constipation Associated With Obstructive Defecation Syndrome (ODS)
|
Phase 4 | |
Recruiting |
NCT05192317 -
Administration of a Natural Molecular Complex in Functional Chronic Constipation
|
N/A | |
Active, not recruiting |
NCT05202028 -
The Efficacy of Massage and Reflexology Applications in Children With Cerebral Palsy
|
N/A | |
Completed |
NCT05734859 -
Drinking Effect of Electrolyzed Alkaline Reduced Water on Functional Constipation
|
N/A | |
Completed |
NCT01007123 -
Study of A3309 in Patients With Chronic Idiopathic Constipation
|
Phase 2 | |
Completed |
NCT00402337 -
Dose-range-finding, Phase 2 Trial of Oral Linaclotide Acetate Administered to Patients With Chronic Constipation
|
Phase 2 | |
Completed |
NCT02961556 -
General Clinical Study of AJG555 in Pediatric Patients With Chronic Constipation
|
Phase 3 |